Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1999 | 09-1999 | 06-1999 | 03-1999 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 15,010 | N/A | N/A | N/A |
| Receivables | 36,290 | N/A | N/A | N/A |
| Inventories | 30,530 | N/A | N/A | N/A |
| Other current assets | 8,240 | 0 | 0 | 0 |
| TOTAL | $90,070 | $N/A | $N/A | $N/A |
| Non-Current Assets | ||||
| Investments And Advances | 21,720 | 0 | 0 | 0 |
| Other Non-Current Assets | 165,830 | 0 | 0 | 0 |
| TOTAL | $187,550 | $N/A | $N/A | $N/A |
| Total Assets | $363,050 | $N/A | $N/A | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Short Term Debt | 3,290 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 9,290 | 0 | 0 | 0 |
| Accrued Expenses | 46,520 | N/A | N/A | N/A |
| Other current liabilities | 7,640 | N/A | N/A | N/A |
| TOTAL | $69,730 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | ||||
| Long Term Debt | 381,700 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 15,960 | 0 | 0 | 0 |
| TOTAL | $403,440 | $N/A | $N/A | $N/A |
| Total Liabilities | $473,190 | $N/A | $N/A | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 100 | N/A | N/A | N/A |
| Retained earnings | -307,350 | N/A | N/A | N/A |
| Other shareholders' equity | -9,920 | 0 | 0 | 0 |
| TOTAL | $-110,140 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $363,050 | $0 | $0 | $0 |